Replimune Group, Inc. (REPL) insider trading

By person

22 insiders · 279 transactions

19.2×

Sushil Patel holds 19.2 times base salary in stock. $13.45M of shares against $700.00K in salary for 2026.

Salary from the company's own proxy. The shares are what Sushil Patel last reported holding, valued at $19.00, the price Common Stock was last bought or sold at on the open market here, on 2 Nov 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Robert Coffin

Director

—

$21.06M (20)

−$21.06M

1,821,872

2.17%

$34.62M

−24.5%

Colin Love

Chief Operating Officer

—

$13.28M (43)

−$13.28M

777,345

0.9260%

$14.77M

−30.5%

Bain Capital Life Sciences Investors, LLC entity

10% owner

$7.50M (1)

—

+$7.50M

2,838,968

3.38%

$53.94M

—

Philip Astley-Sparke

Director

—

$6.90M (27)

−$6.90M

1,362,414

1.62%

$25.89M

−5.5%

Pamela Esposito

Chief Business Officer

—

$6.34M (21) scheduled

−$6.34M

263,436

0.3138%

$5.01M

—

Omega Fund IV, L.P. entity

10% owner

$6.99M (2)

$12.96M (30)

−$5.97M

9,436,760

11.24%

$179.30M

+98.0%

Jason P Rhodes

Director

$14.97M (1)

$17.66M (71)

−$2.69M

19,285

0.0230%

$366.42K

—

Kapil Dhingra

Director

—

$2.26M (5) scheduled

−$2.26M

21,669

0.0258%

$411.71K

—

Jean M. Franchi

Chief Financial Officer

—

$2.01M (8) scheduled

−$2.01M

128,748

0.1534%

$2.45M

—

Forbion Capital Fund III Cooperatief U.A. entity

10% owner

$2.00M (1)

—

+$2.00M

4,721,449

5.62%

$89.71M

—

Hugo Alexander Slootweg

Director

$2.00M (1)

—

+$2.00M

4,721,449

5.62%

$89.71M

—

Sushil Patel

Chief Executive Officer

—

$1.84M (10)

−$1.84M

708,151

0.8436%

$13.45M

—

Konstantinos Xynos

Chief Medical Officer

—

$681.94K (9)

−$681.94K

224,215

0.2671%

$4.26M

+320.7%

Tanya Lewis

Chief Dev. Op. Officer

—

$609.58K (4) scheduled

−$609.58K

135,293

0.1612%

$2.57M

—

Emily Luisa Hill

Chief Financial Officer

—

$480.89K (6)

−$480.89K

215,852

0.2571%

$4.10M

—

Christopher Sarchi

Chief Commercial Officer

—

$412.20K (8)

−$412.20K

180,962

0.2156%

$3.44M

+133.5%

Andrew Schwendenman

Chief Accounting Officer

—

$180.42K (4)

−$180.42K

99,425

0.1184%

$1.89M

−38.9%

Joseph P Slattery

Director

$100.01K (1)

$239.20K (1) scheduled

−$139.20K

6,667

0.0079%

$126.67K

—

Atlas Venture Fund X, L.P. entity

10% owner

—

2,486,296

2.96%

$47.24M

—

Redmile Group, LLC entity

10% owner

—

779,655

0.9288%

$14.81M

—

Howard Kaufman

Chief Medical Officer

—

58,067

0.0692%

$1.10M

—

Andrea Pirzkall

Chief Medical Officer

—

21,500

0.0256%

$408.50K

+2,050%

Replimune Group, Inc.

What the insiders did Net selling

By person